Tirzepatide works on two different mechanisms in the body to do a very similar thing, make you feel fuller. The key differences include: Semaglutide (Ozempic/Wegovy) works through one mechanism and was first to market Tirzepatide (Mounjaro) works through two mechanisms, potentially offering better weight loss results with fewer side effects Tirzepatide tends to be more expensive and less likely to be covered by insurance Semaglutides patent has expired, allowing compounding pharmacies to continue producing it regardless of FDA decisions This distinction explains why compounding pharmacies can continue offering semaglutide while tirzepatide remains in regulatory limbo
The 70 to 80% savings compared to brand-name Ozempic represents the difference between treatment being available or unavailable for the vast majority of people paying out of pocket
Bladder instillations: Bladder instillations involve putting medication directly into the bladder
The production process involves complex peptide synthesis, purification, and formulation steps that must be carried out in tightly controlled pharmaceutical environments
The study was a large international clinical trial that included 17,604 adults, ages 45 and older, who live in 41 countries